Vincerx Pharma, Inc. (VINC)
USD 0.22
(12.97%)
USD 0.22
(12.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -40.45 Million | -59.6 Million | -33.4 Million | -2.27 Million | -34.99 Thousand |
| Net Income | -40.15 Million | -65.36 Million | -39.3 Million | -10.72 Million | -54 Thousand |
| Depreciation & Amortization | 915 Thousand | 939 Thousand | 340 Thousand | 20 Thousand | - |
| Deferred income taxes | 1.56 Million | - | - | - | - |
| Stock-based compensation | 3.56 Million | 10.05 Million | 23.31 Million | 4.38 Million | 1200.00 |
| Change in working capital | -4.19 Million | -1.02 Million | 5.6 Million | -959 Thousand | 10.8 Thousand |
| Other non-cash items | -2.15 Million | -6.59 Million | -23.35 Million | 5.02 Million | 42 Thousand |
| Investing Cash Flow | 41.5 Million | -40.57 Million | -5.25 Million | -65.63 Million | -65.63 Million |
| Investments in PPE | - | - | -5.25 Million | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -11.82 Million | -42.97 Million | - | - | - |
| Sales/Maturities of investments | 53.32 Million | 2.4 Million | - | - | - |
| Other Investing Activities | 41.5 Thousand | -40.57 Thousand | -5 Million | -65.63 Million | -65.63 Million |
| Financing Cash Flow | 114 Thousand | 280 Thousand | 88.45 Million | 64.07 Million | 66.46 Million |
| Debt repayment | - | - | - | -300 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 114 Thousand | 280 Thousand | 41.02 Million | - | - |
| Other Financing Activities | 114.00 | 280.00 | 88.45 Million | 64.37 Million | 66.46 Million |
| Accounts receivables | 328 Thousand | 200 Thousand | - | - | - |
| Accounts payables | -1.56 Million | 1.04 Million | 1.52 Million | 456 Thousand | 35 Thousand |
| Inventory | - | -200 Thousand | - | - | - |
| Other working capital | -2.95 Million | -2.06 Million | 4.08 Million | -1.41 Million | 10.8 Thousand |
| Cash at beginning of period | 11.73 Million | 111.56 Million | 61.79 Million | - | -825.03 Thousand |
| Cash at end of period | 12.85 Million | 11.73 Million | 111.56 Million | 61.79 Million | -34.99 Thousand |
| Capital Expenditure | - | - | -5.25 Million | - | - |
| Effect of forex changes on cash | -40 Thousand | 71 Thousand | -21 Thousand | 65.63 Million | - |
| Net cash flow / Change in cash | 1.12 Million | -99.83 Million | 49.77 Million | 61.79 Million | 790.03 Thousand |
| Free Cash Flow | -40.45 Million | -59.6 Million | -38.66 Million | -2.27 Million | -34.99 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.8 Million | -12.42 Million | -40.15 Million | -4.95 Million | -9.71 Million | -11.15 Million |
| Depreciation & Amortization | 270 Thousand | 264 Thousand | 915 Thousand | 258 Thousand | 254 Thousand | 249 Thousand |
| Deferred income taxes | - | - | 1.56 Million | -1.52 Million | - | -10.51 Million |
| Stock-based compensation | 912 Thousand | 528 Thousand | 3.56 Million | 457 Thousand | 1.33 Million | 385 Thousand |
| Change in working capital | 125 Thousand | -1.3 Million | -4.19 Million | -3.81 Million | 1.68 Million | -2.43 Million |
| Other non-cash items | -3.09 Million | 6.57 Million | -2.15 Million | 1.56 Million | -205 Thousand | 10.45 Million |
| Investing Cash Flow | -8.33 Million | - | 41.5 Million | 5.75 Million | 15.06 Million | 14.8 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -8.33 Million | - | -11.82 Million | - | -1.23 Million | -6.39 Million |
| Sales/Maturities of investments | - | - | 53.32 Million | 5.75 Million | 16.29 Million | 21.2 Million |
| Other Investing Activities | -8.33 Million | - | 41.5 Thousand | 5750.00 | 15.06 Thousand | 14.8 Thousand |
| Financing Cash Flow | 17 Million | 5000.00 | 114 Thousand | 18 Thousand | - | 93 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17 Million | 5000.00 | 114 Thousand | 18 Thousand | - | 93 Thousand |
| Other Financing Activities | 17 Million | 5000.00 | 114.00 | 18.00 | - | -93 Thousand |
| Accounts receivables | - | -131 Thousand | 328 Thousand | 9000.00 | - | - |
| Accounts payables | -778 Thousand | -183 Thousand | -1.56 Million | -565 Thousand | -471 Thousand | -2.64 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 772 Thousand | -992 Thousand | -2.95 Million | -3.26 Million | 2.15 Million | 206 Thousand |
| Cash at beginning of period | 5.19 Million | 12.85 Million | 11.73 Million | 15.14 Million | 6.74 Million | 4.55 Million |
| Cash at end of period | 8 Million | 5.19 Million | 12.85 Million | 12.85 Million | 15.14 Million | 6.74 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -24 Thousand | 72 Thousand | -40 Thousand | -43 Thousand | -17 Thousand | -10 Thousand |
| Net cash flow / Change in cash | 2.81 Million | -7.66 Million | 1.12 Million | -2.29 Million | 8.39 Million | 2.19 Million |
| Free Cash Flow | -5.82 Million | -7.73 Million | -40.45 Million | -8.01 Million | -6.64 Million | -12.69 Million |
300126
MDVT
IAG
NOM
EAATF
ATRL